ATR inhibitor camonsertib (RP-3500) suppresses early-stage erythroblasts by mediating ferroptosis von Levy, M., Ferraro, G.B., Planoutene, M., Li, L., Han, Y., Varicchio, L., Fournier, S., An, X., Morris, S.J., Koehler, M., Hoffman, R., Fretland, A.J., Roulston, A., Ginzburg, Y.Z.

Volltext

Abstract GS3-01: A randomized placebo controlled phase III trial of low dose tamoxifen for the prevention of recurrence in women with operated hormone sensitive breast ductal or lo... von DeCensi, A, Puntoni, M, Guerrieri Gonzaga, A, Avino, F, Cortesi, L, Donadio, M, Pacquola, M, Falcini, F, Gulisano, M, Digennaro, M, Tienghi, A, Cagossi, K, Pinotti, G, Varicchio, C, Caviglia, S, Boni, L, Bonanni, B

Volltext